Post-approval studies (Phase 4)Study completedNCT00035204
What this trial is testing
The Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease
Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63